United Imaging Town Unveils Prospectus: A Government-Enterprise Collaborative Model Driving Global Innovation in High-End Medical Equipment

Driven by the wave of globalization and led by technological innovation, the development of the medical and healthcare industry has become a core issue of global attention. Particularly for China, faced with the challenge of a moderately aging population and a widespread increase in health awareness among residents, the Chinese medical and healthcare industry is ushering in vast development space and unlimited potential.

To further promote the development of the industry in a more “open, inclusive, balanced, and mutually beneficial” direction, on November 21, the Administrative Committee of Shanghai Jiading Industrial Zone, Shanghai Jiading Industrial Zone Development (Group) Co., Ltd., and United Imaging Group joined hands with Shanghai Jiabei Biopharmaceutical Technology Development Co., Ltd. and the Shanghai High-End Medical Equipment Industrial Park to host“Jiading Industrial Park Medical and Health Industry Summit and United Imaging Town Development and Construction Promotion” (hereinafter referred to as: the Summit)。

This Summit is themed“New Quality Drivers, Industry-City Integration”Themed around this topic, the event invited over 50 speakers to share their insights in person, including Academician Gu Xiaosong of the Chinese Academy of Engineering, leading experts from prominent Grade-A tertiary hospitals, core executives from United Imaging Group, key officials from relevant government departments, representatives from upstream and downstream enterprises in the medical imaging industry, representatives from implantable and interventional device companies, providers of overseas expansion services, and representatives from financial, securities, and investment institutions.

Meanwhile, this year’s summit focuses onMedical Imaging Equipment, Implantable and Interventional Devices, Enterprise Global ExpansionThree major hot topics, facilitated through three key engagement formats—forums, site visits, and exhibition booths—successfully attracted the active participation of over 400 professional attendees, focusing on innovation and development opportunities in the healthcare industry from multiple perspectives and dimensions.

At the Opening Ceremony,Lu Fangzhou, Secretary of the Jiading District Committee of the Communist Party of ChinaIn his address, he pointed out that Jiading, as one of the first pilot health cities in China, has always prioritized the development of the medical and healthcare industry as its main focus for cultivating new quality productive forces and strengthening new growth drivers. By strengthening planning guidance, it has clarified an industrial spatial layout of “one axis, one town, two valleys, and two zones.” By reinforcing industrial clustering, it has gathered more than 1,300 biomedical enterprises, including United Imaging Healthcare, Sanyou Medical, Aipuqiang, Yixin Medical, and Osida. By enhancing policy empowerment, it has introduced a series of high-impact policy measures focused on innovative R&D and project implementation. By fostering a supportive ecosystem, it has promoted deep integration among industry, academia, research, clinical practice, and application through initiatives such as deepening medical-engineering collaboration and establishing shared laboratories.

Lu Fangzhou stated that Jiading is currently implementing the decisions and deployments of the Municipal Party Committee and Municipal Government, focusing on niche segments of high-end medical devices. By leveraging innovation drivers such as large enterprises, major research institutes, and academies, Jiading is continuously optimizing its industrial ecosystem. It is exploring a new development model led by flagship enterprises, featuring the agglomeration of upstream and downstream industry clusters and the deep integration of “industry, city, and people,” thereby accelerating the growth of the biopharmaceutical industry toward the 100-billion-yuan mark. The most representative example of this effort is “United Imaging Town.” Lu expressed hope that both the government and enterprises will further strengthen collaboration, stay focused on their goals, and capitalize on current momentum to rapidly realize the functional, visual, and economic benefits of United Imaging Town, accelerating its development into a demonstration model for industry-city integration. The aim is to enhance the competitiveness of “industry,” optimize the functions of the “city,” and create convenient and livable living spaces, establishing a benchmark for the integrated development of production, life, and ecology.

Lu Fangzhou, Secretary of the Jiading District Committee of the Communist Party of China in Shanghai

Against the backdrop of Jiading District’s continuous efforts to optimize its healthcare industry layout and strengthen policy support, the summit has specially invited two leading experts in the field to deliver keynote addresses, jointly exploring ways to further invigorate the healthcare industry and drive industrial upgrading.

First,Academician Gu Xiaosong of the Chinese Academy of EngineeringDelivering a keynote address titled “Technological Advancement and the High-Quality Development of Biomedicine,” he emphasized the critical role of technological progress in the healthcare sector, particularly in the application of artificial intelligence and big data. Furthermore, Academician Gu Xiaosong shared recent advances in his research on brain-computer interfaces and tissue-engineered nerve regeneration, calling for strengthened independent innovation to enhance China’s competitiveness in the global biopharmaceutical industry. Finally, he outlined his vision for the future of the healthcare industry, highlighting the development of the intelligent medical engineering discipline and the pivotal role of Yangtze River Delta integration in driving high-quality development.

 Academician of the Chinese Academy of Engineering, Gu Xiaosong

Zheng Junhua, Secretary of the Party Committee of Renji Hospital Affiliated to Shanghai Jiao Tong University School of MedicineTitle: “What Does High-Quality Hospital Development Require? — Establishment and Application Cases of Key Technologies in the Diagnosis and Treatment of Renal Cell Carcinoma”It is clearly stated that the core of the healthcare industry will ultimately return to hospitals and patients themselves. Taking the diagnosis and treatment of renal cell carcinoma as an example, he emphasizes that when building high-level research-oriented disciplines, hospitals need to focus on three key areas (“Three Focuses”): addressing major diseases, enhancing original innovation capabilities, and developing talent cultivation systems. In fostering new quality productive forces within disciplines, efforts should be directed toward five aspects (“Five Efforts”): discipline optimization, self-reliance in high technology, investment in frontier technologies, aggregation of production factors, and empowerment through information technology. These measures aim to comprehensively promote high-quality hospital construction and development, contributing to the Healthy China initiative.

 Zheng Junhua, Secretary of the Party Committee of Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

As an innovation hub for Shanghai’s healthcare industry, Jiading District has proactively integrated into the city’s “1+5+X” biomedical industry layout in recent years. Leveraging its spatial planning framework of “One Axis, One Town, Two Valleys, and Two Zones,” it is striving to build a hundred-billion-yuan biomedical industry cluster, with high-performance medical equipment and precision medicine as its key pillars.

According to official data released by Jiading District, the total output of its biopharmaceutical industry reached RMB 24.81 billion in the first three quarters of this year, ranking fourth in terms of production scale and third in growth rate among all districts in Shanghai. This demonstrates the strong development momentum of Jiading’s biopharmaceutical sector and the positive impact on regional economic growth.

As the summit’s discussions progressed in depth, stakeholders from across the industry continued to converge, with numerous innovators and key industry elements delving into the core of the sector to collaboratively build “United Imaging Town”—a premier, cutting-edge, and intelligent pilot demonstration zone.

The promotion of “United Imaging Town” was one of the core agendas of this summit and a key focus area.In this segment, as the "chain leader" of the industrial chain,Xue Min, Chairman of United Imaging Healthcare Group, delivered a keynote speech themed “Integration of Industry and City: Joining Hands to Build a World-Class Innovation Ecosystem for High-End Medical Equipment.”

Xue Min emphasized that the goal of “United Imaging Town” is to establish itself as a global hub for high-end medical equipment, noting that Jiading District possesses inherent advantages for achieving this objective. Meanwhile, Xue introduced United Imaging Group’s development history and future plans to the attendees, highlighting its layout of seven subsidiaries spanning fields such as imaging equipment, artificial intelligence, surgical robotics, and high-end imaging services. He also underscored the group’s achievements in technological innovation and patent applications. Looking ahead, Xue expressed confidence that, with government support and the joint efforts of industry elites, “United Imaging Town” will realize its ambitious goal of becoming a world-class innovation ecosystem for high-end medical equipment in the coming years.

Xue Min, Chairman of United Imaging Healthcare Group

Subsequently, in the promotional presentation for “United Imaging Town,”Li Chao, Secretary of the Party Working Committee and Executive Deputy Director of the Management Committee of Jiading Industrial ZoneThe plan and vision for “United Imaging Town” were introduced in detail, with emphasis placed on the fact that, on the innovative land of Jiading, “United Imaging Town” is bound to become the optimal hub for the high-end medical equipment industry and a premier model for the integrated development of industry and urban areas. He expressed his expectation to work with all parties to build a benchmark town featuring the integration of production, living, and ecology (“three-life” integration) and the unity of city, people, and industry, guided by an international perspective and world-class goals.

Li Chao, Secretary of the Party Working Committee and Executive Deputy Director of the Management Committee of Jiading Industrial Zone

According to reports, the “United Imaging Town,” jointly developed by Jiading District as the “chain leader” and United Imaging Group as the “chain owner,” adopts an integrated model of industry-city development that harmonizes urban infrastructure, talent, and industry. With a total planned area of 9.5 square kilometers, the project aims to build a world-class cluster for high-end medical equipment industries and create a future-oriented innovation hub for corporate talent, supported by high-quality services. Upon completion, the town is expected to fully unlock regional development potential, adding 47,000 residents, releasing 203 hectares of land for industrial use, and creating 55,000 new jobs. The total output value is projected to exceed RMB 100 billion, truly realizing a new dynamic pattern of vibrant, sustainable, and upward growth among industry, city, and people.

Subsequently, inAppointment Ceremony of the “Honorary Mayor” of United Imaging TownOn,Gao Xiang, Deputy Secretary of the Jiading District Committee of the Communist Party of China and District Mayor, to Xue Min, Chairman of United Imaging GroupThe “Honorary Town Mayor” golden key was presented. This ceremony not only marks the further deepening of the cooperative relationship between Jiading District and United Imaging Healthcare, but also symbolizes the important role of United Imaging Town in regional development. In the future, relying on the leadership of Jiading Industrial Zone and United Imaging Healthcare, United Imaging Town will strengthen cooperation with all parties to build an international high-end medical equipment industrial cluster integrating R&D, production, living, and services, contributing Chinese wisdom and strength to the global healthcare cause.

As one of the highlights of this summit, the Jiading District Medical and Health Industry Chain Alliance was officially established.Lu Zufang, Member of the Standing Committee of the Jiading District Committee of the Communist Party of China and Executive Deputy District Mayor; Lu Qiang, Deputy Director of the Standing Committee of the Jiading District People’s Congress; and Zhao Zhijian, Secretary of the Party Committee and Director of the Jiading District State-owned Assets Supervision and Administration Commission, respectively presented certificates to representative members of the alliance, including government functional departments, chain-leading enterprises, research institutions, clinical institutions, investment firms, and financial institutions. Moving forward, alliance members will collaborate closely, share resources, jointly address industry challenges, and explore new models of cooperation and business opportunities.

The establishment of the Jiading District Medical and Health Industry Chain Alliance marks a new stage of development for Jiading District’s medical and health industry.In this regard,Zhang Min, Deputy Secretary of the Party Working Committee and Deputy Director of the Administrative Committee of Jiading Industrial Zone, as well as Secretary of the Party Committee and Chairman of the Group CompanyAt the alliance promotion presentation, it was pointed out that the Jiading District Medical and Health Industry Chain Alliance will integrate resources from government, industry, academia, research institutions, and healthcare providers. Focusing on strategic development, industrial clustering, and the aggregation of key factors, the Alliance will clarify the roles of chain leaders and leading enterprises, as well as its operational mechanisms and division of responsibilities. Supported by four core mechanisms, the Alliance will drive the formulation of industrial plans, development of industrial carriers, improvement of the industrial ecosystem, provision of policy support, research on industrial funds, and upgrading of industrial platforms, thereby comprehensively enhancing the competitiveness of the medical and health industry chain and helping Shanghai’s biopharmaceutical industry reach new heights. Meanwhile, Zhang Min, representing the Jiading District Medical and Health Industry Chain Alliance, sincerely invited high-quality enterprises in the medical and health sector to join forces, deepen their development in the Jiading Industrial Zone, and co-create a promising future.

 Zhang Min, Party Secretary and Chairman of Jiading Industrial Zone Group

On-site, 16 key medical and health industry projects in Jiading Industrial Zone were signed, with a total investment of RMB 970 million.Through the implementation of these key collaborative projects, Jiading District will further promote the clustered development of the medical and healthcare industry, strengthen collaborative innovation across the upstream and downstream segments of the industrial chain, and empower the development of Shanghai’s biopharmaceutical industry.

These significant initiatives will drive industrial innovation and upgrading by integrating resources and fostering collaboration, further strengthening Jiading District’s position as a leader in China’s medical and health industry. Leveraging the strength of the Jiading District Medical and Health Industry Chain Alliance, Jiading District and “United Imaging Town” will attract more investment and talent, accelerate the translation of scientific and technological achievements in the medical and health sector, improve the quality and efficiency of medical services, promote the implementation of the Healthy China strategy on a broader scale, and make positive contributions to enhancing national health levels and fostering sustainable economic and social development.

The second half of the summit featured three parallel forums centered on three hot topics: “Imaging Equipment,” “Implantable and Interventional Devices,” and “Global Expansion of Enterprises.” More than 40 representatives from industry associations, leading companies, and investment institutions were invited to share their innovative practices in developing high-end healthcare industry clusters from a global perspective.

The Medical Imaging Equipment Industry Innovation and Development Forum is organized byZhang Mengru, Partner at Leli CapitalModerator. In this session, the Summit is honored to have invited clinical experts, leading medical imaging equipment manufacturers, AI imaging companies, upstream imaging industry players, and seasoned investors to deliver keynote speeches, namely:Liu Shiyuan, Director of the Department of Radiology at Shanghai Changzheng Hospital; Tan Guosheng, General Manager and Co-CEO of United Imaging Healthcare; Jia Zukang, Head of the Shanghai Imaging Product Line at Mindray Medical; Huang Jiaxiang, Vice President of Wandong Medical and Founder and CEO of Wanli Cloud Medical; Yang He, Founder and CEO of Vimai Medical; Tian Yuan, Co-founder of Vinno Technology; Wu Guojin, Board Secretary of Intalight Saiwei; and Zhang Feng, Chairman of OZEDA Medical Device Services Group.. Eight panelists explored the latest trends and technological breakthroughs in the medical imaging industry from comprehensive and multi-dimensional perspectives, offering valuable insights and reflections for the sector’s development.

During the industry roundtable session on “Innovation and Development Opportunities in Medical Imaging Equipment,”Wang Chao, President of the Molecular Imaging Business Unit at United Imaging Healthcare; Huang Jiaxiang, Vice President of Wandong Medical and Founder & CEO of Wanli Cloud Medical; Shan Bo, Chief Technology Officer for the Healthcare Industry at MathWorks China; Zhang Qinghui, Deputy General Manager of Xinhong Electronics; Liu Lei, Managing Director of Jinhai Medical; and moderator Zhang MengruIn-depth discussions were held on issues such as innovation in the medical imaging industry, internationalization, penetration into lower-tier markets, domestically produced core components, and the urgent needs of hospitals.

The panelists generally agreed that innovation is the core of industry development, requiring multidisciplinary collaboration and cross-boundary thinking, while also emphasizing the importance of intellectual property protection. Regarding internationalization and penetration into lower-tier markets, the panelists believed that neither should be overlooked; instead, priorities should be determined based on each enterprise’s stage of development and market demands. As for domestically produced core components, they considered these key to enhancing the competitiveness of China’s medical equipment industry, necessitating joint efforts from enterprises and research institutions. Finally, the panelists pointed out that hospitals’ most urgent needs are talent development and technological innovation, aimed at improving the quality and efficiency of medical services.

The Frontier Innovation Forum on Implantable and Interventional Medical Devices was hosted by Gu Shenghan, Executive Director of Shanlan Capital, who invitedShen Li, Secretary-General of the China Cardiovascular Doctors Innovation Club (CCI) and Chief Physician in the Department of Cardiology at Zhongshan Hospital, Fudan University; Liu Weiting, General Manager of Greater China for Abbott’s Structural Heart Division; Zhang Bing, Head of Government and Corporate Affairs at Double Medical Technology; Zhong Wei, Chief Scientist and Co-founder of Yixin Medical; Luo Fuliang, Co-founder and President of HJY Medical; Chen Chong, Director and Marketing Director at Zhongtian Medical; Sun Xiaolu, Managing Partner at Proxima Ventures; and Zhang Jie, Founder and General Manager of Haichuang Shenghong.Delivering keynote addresses to jointly focus on the development trends and market potential of implantable and interventional medical devices.

In the subsequent roundtable discussion session,Zhu Chao, Board Secretary of Batai Medical; Zhang Xiaonong, CEO of Aoruiji Medical; Zhang Bo, Founder and Chairman of Aoda Zhisheng; Yang Xi, Co-founder & CEO of Nuopu Regenerative Medicine; and moderator Gu ShenghanCentered on the theme of “The Innovation Path for Implantable and Interventional Device Companies,” participants jointly explored the challenges posed by the fiercely competitive landscape within China’s entrepreneurial ecosystem and environment, as well as strategies to stand out from the competition by building differentiated products and corporate positioning.

The panelists emphasized the importance of deeply identifying clinical pain points, leveraging proprietary technological and manufacturing advantages, and sustaining innovation. In response to the intense competition (“involution”) within the medical device sector, entrepreneurs proposed strategies such as adopting an agile “small steps, fast pace” approach, aligning with physicians’ established workflows, delivering superior solutions, and prioritizing clinical data and empirical evidence. Regarding cross-departmental promotion and commercialization, they discussed the importance of collaborating with B-end clients, controlling structural costs, and identifying appropriate sales and marketing pathways across different clinical departments. Finally, in light of the current challenging market environment, the panelists noted that this is an era of “survival of the fittest,” requiring companies to strengthen their core competencies and meet challenges through collaboration and enhanced efficiency, while anticipating the next cycle of economic and industrial development.

The Medical Device Global Expansion Forum and the Global Healthcare Innovative Products Export Demand Matchmaking Event invited Wang Li, Head of the Healthcare Sector Team at Haitong Securities, to serve as the moderator. InvitedCai Zixuan, Director of the International Department of the China United Nations Procurement Promotion Association; Cai Tao, Board Secretary and Chief Investment Officer of United Imaging Healthcare; Wan Jun, Founder and Chairman of Jilian Group; Qiu Lisha, Deputy General Manager of Midea InnoChina; Sun Daguang, Vice President of Purely Medical and Global Registration Expert for Medical Devices and IVD; Wang Haijiao, Deputy General Manager of GTJA Capital; Mo Duoping, Chairman and General Manager of RegTech; Yang Jia, Senior Vice President of Chu JinglingParticipate in the keynote speech, offering multiple perspectives from channel experts, third-party service providers for global expansion, and seasoned investors to jointly discuss the pain points and opportunities in the internationalization of medical devices.

The industry roundtable session, themed “Reflections on the Global Expansion and International Cooperation of Medical Device Innovations,” invitedCai Tao, Board Secretary and Chief Investment Officer of United Imaging Healthcare; Wang Guoliang, Vice President of Unisplendour Technology; Cao Changqing, Founder and Chairman of Juyi Technology; Peng Huiqun, Founder and Chairman of Puchuang Medical; Mo Duoping, Chairman and General Manager of Regentech; Yin Liang, General Manager of Zhoutong Health; and Chen Qing, Head of Business Development at BASEL MEDICALIt focuses on the multiple adjustments and opportunities faced by Chinese enterprises expanding overseas.

Panelists generally agreed that technological innovation and R&D are the core drivers of successful global expansion for enterprises. They emphasized the importance of international cooperation and academic exchange in building brand trust, as well as the necessity of localization strategies to address the diverse needs and cultural differences of various markets. Regarding global supply chain management, participants discussed its critical role in navigating geopolitical shifts and market fluctuations. Compliance and international certifications were viewed as prerequisites for entering overseas markets, while market positioning and pricing strategies were identified as key tools for enhancing product competitiveness. Furthermore, panelists shared their strategies for overcoming challenges in global expansion, highlighting the significance of long-term planning and patient capital in the process of corporate globalization.

The “United Imaging Town Development and Construction Promotion Conference & Medical Health Industry Summit” has successfully concluded, but the excitement is far from over.

In the highly competitive and promising global biopharmaceutical industry, achieving deep integration across upstream and downstream segments of the industrial chain, as well as across horizontal sectors, is a key strategy for advancing the industry toward high-quality development. Looking ahead to the future of a hundred-billion-yuan-level industrial cluster, Jiading Industrial Zone and United Imaging Healthcare will leverage their resource advantages to attract upstream and downstream enterprises, foster the formation of larger-scale industrial clusters, and provide comprehensive service support and leadership throughout the entire lifecycle of industrial development. Together, they aim to build “United Imaging Town,” a world-class innovation ecosystem for high-end medical equipment characterized by deep collaboration and integrated development among industry, academia, research, and healthcare institutions.

Reference Article:

1. “Third Fastest Growth in the City! Jiading’s Biopharmaceutical Industry Is Moving Toward Bright Prospects, Aiming to Reach a Trillion-Yuan Industrial Chain Output Value” — Jiading Market Supervision Administration

2. “25 Projects! Signing Amount Exceeds 2 Billion, Jiading’s Biopharmaceutical Industry Innovates and Develops!” Invest in Jiading